Evidence map›Paper›PMID 41087178›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2025

[Clinical efficacy and safety of Octocog alfa in Chinese patients with hemophilia A: One-year follow-up results from the Antihemophilic Factor Hemophilia A Outcome Database (AHEAD) study].

R H Wu, Z Y Li, J Sun, X Du, X S Zhang, Y Wang, Q Hu, R F Zhou, J Gu, R Guerra and 1 more

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

R H WuBeijing Children's Hospital, Capital Medical University, Beijing 100045, China.
Z Y LiThe Affiliated Hospital of Xuzhou Medical University, Xuzhou 221132, China.
J SunNanfang Hospital, Nanfang Medical University, Guangzhou 515399, China.
X DuShenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518035, China.
X S ZhangShandong Blood Center, Jinan 250013, China.
Y WangShenzhen Children's Hospital, Shenzhen 518000, China.
Q HuTongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan 430030, China.
R F ZhouNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing 210008, China.
J GuTakeda Development Center Americas, Inc., Cambridge, MA, USA.
R GuerraTakeda Development Center Americas, Inc., Cambridge, MA, USA.
R C YangInstitute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Factor VIIIHemophilia AAdolescentAdultChildDatabases, FactualEast Asian PeopleFollow-Up StudiesHumansMaleRecombinant ProteinsTreatment OutcomeYoung AdultFactor VIIIRecombinant Proteins1-year follow-upClinical efficacyHemophilia ARecombinant human coagulation factor Ⅷ

Identifiers

PMID41087178
PMCPMC12541489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.